Evidence map›Paper›PMID 28890886›Full record

ArticleInternational journal of molecular and cellular medicine2017

Development of a Novel Anti-Adhesive Vaccine Against

Sobhan Faezi, Ahmad Reza Bahrmand, Mehdi Mahdavi, Seyed Davar Siadat, Iraj Nikokar, Soroush Sardari

Open access · greenAbstract read
In one paragraph

Article in International journal of molecular and cellular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sobhan FaeziDepartments of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Ahmad Reza BahrmandDepartments of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Mehdi MahdaviDepartments of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Seyed Davar SiadatDepartments of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Iraj NikokarLaboratory of Microbiology and Immunology of Infectious Diseases, Faculty of paramedicine, Guilan University of Medical Sciences, Rasht, Iran.
Soroush SardariBiotechnology Research Center, Drug Design and Bioinformatics Group, Pasteur Institute of Iran, Tehran, Iran.
Pasteur Institute of Iran · IRBiotechnology Research Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type IV pili (T4P) are major virulence factors of

Indexed as

disulfide looppET26bPseudomonas aeruginosatype IV pilivaccine

Identifiers

PMID28890886
PMCPMC5581551
OpenAlexW2739632850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.